Literature DB >> 21987588

Standardization efforts of digital pathology in Europe.

Marcial García Rojo1, Christel Daniel, Thomas Schrader.   

Abstract

BACKGROUND: EURO-TELEPATH is a European COST Action IC0604. It started in 2007 and will end in November 2011. Its main objectives are evaluating and validating the common technological framework and communication standards required to access, transmit, and manage digital medical records by pathologists and other medical specialties in a networked environment. BUSINESS MODELLING: Working Group 1, "Business Modelling in Pathology," has designed main pathology processes - Frozen Study, Formalin Fixed Specimen Study, Telepathology, Cytology, and Autopsy - using Business Process Modelling Notation (BPMN). INFORMATICS STANDARDS IN PATHOLOGY: Working Group 2 has been dedicated to promoting the application of informatics standards in pathology, collaborating with Integrating Healthcare Enterprise (IHE), Digital Imaging and Communications in Medicine (DICOM), Health Level Seven (HL7), and other standardization bodies.
CONCLUSIONS: Health terminology standardization research has become a topic of great interest. Future research work should focus on standardizing automatic image analysis and tissue microarrays imaging.

Entities:  

Mesh:

Year:  2012        PMID: 21987588      PMCID: PMC4605716          DOI: 10.3233/ACP-2011-0036

Source DB:  PubMed          Journal:  Anal Cell Pathol (Amst)        ISSN: 2210-7177            Impact factor:   2.916


  2 in total

1.  New methods for clinical pathways-Business Process Modeling Notation (BPMN) and Tangible Business Process Modeling (t.BPM).

Authors:  Hubert Scheuerlein; Falk Rauchfuss; Yves Dittmar; Rüdiger Molle; Torsten Lehmann; Nicole Pienkos; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

Review 2.  Human Factors and Human-Computer Considerations in Teleradiology and Telepathology.

Authors:  Elizabeth A Krupinski
Journal:  Healthcare (Basel)       Date:  2014-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.